AI Verdict
IMAX has stronger fundamentals based on our AI analysis.
IMDX vs IMAX Fundamental Comparison
| Metric | IMDX | IMAX |
|---|---|---|
| Revenue | $4.1M | $410.2M |
| Net Income | $-50.2M | $34.9M |
| Net Margin | -1,238.5% | 8.5% |
| ROE | N/A | 10.3% |
| ROA | -195.0% | 3.9% |
| Current Ratio | 1.27x | N/A |
| Debt/Equity | N/A | 0.00x |
| EPS | $-1.65 | $0.63 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMDX vs IMAX: Frequently Asked Questions
Is IMDX or IMAX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMAX has stronger fundamentals. IMDX is rated STRONG SELL (88% confidence) while IMAX is rated HOLD (78% confidence). This is not investment advice.
How does IMDX compare to IMAX fundamentally?
Insight Molecular Diagnostics Inc. has ROE of N/A vs IMAX CORP's 10.3%. Net margins are -1,238.5% vs 8.5% respectively.
Which stock pays higher dividends, IMDX or IMAX?
IMDX has a dividend yield of N/A or no dividend while IMAX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMDX or IMAX for long term?
For long-term investing, consider that IMDX has STRONG SELL rating with 88% confidence, while IMAX has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMDX vs IMAX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMDX vs IMAX, the AI consensus favors IMAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.